Clinical Trial: The Incidence of Extended-spectrum β-lactamase (ESBL) Klebsiella Pneumonia in Patient on Renal Replacement Therapy

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title:

Brief Summary: The prevalence of ESBL Klebsiella pneumonia was higher in patient with renal replacement therapy.

Detailed Summary:
Sponsor: Inje University

Current Primary Outcome: The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy [ Time Frame: During hospitalization ]

The prevalence of ESBL Klebsiella pneumonia in renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011)


Original Primary Outcome: Same as current

Current Secondary Outcome: The prevalence of ESBL Klebsiella pneumonia in patient with pneumonia and renal replacement therapy [ Time Frame: during hospitalization ]

The prevalence of ESBL Klebsiella pneumoina in patient with pneumonia and renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011)


Original Secondary Outcome: The prevalence of ESBL Klebsiella pneumoina in patient with pneumonia and renal replacement therapy [ Time Frame: during hospitalization ]

The prevalence of ESBL Klebsiella pneumoina in patient with pneumonia and renal replacement therapy during hospitalization up to 8 years (from 2004 to 2011)


Information By: Inje University

Dates:
Date Received: May 29, 2012
Date Started: March 2012
Date Completion:
Last Updated: June 4, 2012
Last Verified: June 2012